AxoGen appoints Naor as Chief Financial Officer

Axogen announced the appointment of Nir Naor as Chief Financial Officer, effective immediately. A senior finance executive with more than 20 years of experience primarily in the life sciences industry, he replaces Peter Mariani, who will depart Axogen following a brief transition period. The move aligns the executive team with the Company’s financial management and investor relations needs going forward as Axogen focuses on continued revenue growth across both business categories while driving toward being cash flow positive and profitable. Naor has served as the CFO of Arbor Pharmaceuticals and supported its strategic pivot.